Posts in tag

generics


Evergreening strategies delay market entry for generic medicines to the detriment of the Australian community and there is a lack of evidence to support extending market exclusivity for pharmaceuticals, according …

Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. …

Apotex has announced that it will be ceasing supply of two PBS listed prescription products from its portfolio. The PBS delisting date is yet to be confirmed, and stock will …

Four policy priorities that will safeguard affordable access to medicines in Australia while ensuring the generic and biosimilar medicines industry remains viable have been agreed to by the Federal Government. …

The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …

From today, the Generic Medicines Industry Association will be known as the Generic and Biosimilar Medicines Association. After patents expire on brand name medicines, affordable generic and biosimilar medicines deliver …

As trade ministers meet in Hawaii on 28-31 July in an effort to finalise the Trans Pacific Partnership, the Public Health Association of Australia and other stakeholders say that lives …

Pharmacies offer overall better prices on open-selling medicines, according to a new report from Choice – as well as better customer service. Choice compared the prices of common medicines available …

A token increase in the quota of sugar into the United States is not grounds for trading off Australian access to cheaper generic medicines, says the Public Health Association of …

More than 2000 brands of common medicines could be slashed in price, some by as much as 50%, from next year, Minister for Health Sussan Ley says under the Government’s proposed PBS package.

The new Strategic Agreement signed by the Generic Medicines Industry Association and Australian Government recognises the essential role of generic medicines and biosimilars in delivering affordable healthcare through the PBS, …

The Generic Medicines Industry Association has welcomed the PBAC’s decision to consider “a” flagging of biosimilars, and to list biosimilar insulin (Basaglar) on the PBS. Basaglar is the first biosimilar …